[go: up one dir, main page]

EP1198468A4 - Proteines d'enveloppe virale stabilisee et utilisations - Google Patents

Proteines d'enveloppe virale stabilisee et utilisations

Info

Publication number
EP1198468A4
EP1198468A4 EP00944801A EP00944801A EP1198468A4 EP 1198468 A4 EP1198468 A4 EP 1198468A4 EP 00944801 A EP00944801 A EP 00944801A EP 00944801 A EP00944801 A EP 00944801A EP 1198468 A4 EP1198468 A4 EP 1198468A4
Authority
EP
European Patent Office
Prior art keywords
envelope proteins
viral envelope
stabilized viral
stabilized
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00944801A
Other languages
German (de)
English (en)
Other versions
EP1198468A1 (fr
Inventor
James M Binley
Norbert Schuelke
William C Olson
Paul J Maddon
John P Dept Of Microbiol Moore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Progenics Pharmaceuticals Inc
Aaron Diamond AIDS Research Center
Original Assignee
Progenics Pharmaceuticals Inc
Aaron Diamond AIDS Research Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Progenics Pharmaceuticals Inc, Aaron Diamond AIDS Research Center filed Critical Progenics Pharmaceuticals Inc
Publication of EP1198468A1 publication Critical patent/EP1198468A1/fr
Publication of EP1198468A4 publication Critical patent/EP1198468A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP00944801A 1999-06-25 2000-06-23 Proteines d'enveloppe virale stabilisee et utilisations Withdrawn EP1198468A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US340992 1989-04-20
US34099299A 1999-06-25 1999-06-25
PCT/US2000/017267 WO2001000648A1 (fr) 1999-06-25 2000-06-23 Proteines d'enveloppe virale stabilisee et utilisations

Publications (2)

Publication Number Publication Date
EP1198468A1 EP1198468A1 (fr) 2002-04-24
EP1198468A4 true EP1198468A4 (fr) 2003-07-30

Family

ID=23335807

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00944801A Withdrawn EP1198468A4 (fr) 1999-06-25 2000-06-23 Proteines d'enveloppe virale stabilisee et utilisations

Country Status (6)

Country Link
EP (1) EP1198468A4 (fr)
JP (1) JP2003509013A (fr)
AU (1) AU782123B2 (fr)
CA (1) CA2370517A1 (fr)
HK (1) HK1046911A1 (fr)
WO (1) WO2001000648A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6710173B1 (en) 1999-06-25 2004-03-23 Progenics Pharmaceuticals, Inc. Stabilized viral envelope proteins and uses thereof
CA2459426A1 (fr) * 2001-09-06 2003-03-20 Progenics Pharmaceuticals, Inc. Mutants de glycoproteines d'enveloppe du vih et leurs utilisations
AU2002360673A1 (en) * 2001-12-17 2003-06-30 The Government Of The Usa As Represented By The Secretary Of The Dept. Of Health And Human Services Gp41 inhibitor
WO2003087757A2 (fr) * 2002-04-05 2003-10-23 Progenics Pharmaceuticals, Inc. Glycoproteines de l'enveloppe du virus d'immunodeficience humaine liees a des particules, compositions et procedes associes
WO2004110384A2 (fr) * 2003-06-12 2004-12-23 Vaxgen, Inc. Glycoproteines d'enveloppe du vih-1 a structure disulfure inhabituelle
KR100560468B1 (ko) 2003-09-16 2006-03-13 삼성에스디아이 주식회사 화상 표시 장치와 그 표시 패널
WO2007107090A1 (fr) * 2006-03-17 2007-09-27 Huawei Technologies Co., Ltd. Procédé et dispositif de transfert souple dans un système de communication à accès mrof
WO2008063331A2 (fr) 2006-10-23 2008-05-29 Progenics Pharmaceuticals, Inc. Polypeptides d'enveloppe gp140 modifiés en provenance d'isolats du vih-1, compositions, complexes trimériques et utilisations de ceux-ci
WO2013189901A1 (fr) * 2012-06-18 2013-12-27 Novartis Ag Gp120 stabilisée
MX2021004273A (es) 2018-10-17 2021-12-10 Glaxosmithkline Biologicals Sa Proteinas de citomegalovirus modificadas y complejos estabilizados.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5886163A (en) * 1993-03-26 1999-03-23 Progenics Pharmaceuticals, Inc. HIV-1 antigens, antibody compositions related thereto, and therapeutic and prophylactic uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05506669A (ja) * 1990-09-25 1993-09-30 ペプテック　（ユーケイ）　リミテッド エイズ治療法及びワクチン

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5886163A (en) * 1993-03-26 1999-03-23 Progenics Pharmaceuticals, Inc. HIV-1 antigens, antibody compositions related thereto, and therapeutic and prophylactic uses thereof

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
BINLEY J M ET AL: "A RECOMBINANT HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 ENVELOPE GLYCOPROTEIN COMPLEX STABILIZED BY AN INTERMOLECULAR DISULFIDE BOND BETWEEN THE GP120 AND GP41 SUBUNITS IS AN ANTIGENIC MIMIC OF THE TRIMERIC VIRION-ASSOCIATED STRUCTURE", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 74, no. 2, January 2000 (2000-01-01), pages 627 - 643, XP002939087, ISSN: 0022-538X *
BURTON DENNIS R ET AL: "Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody.", SCIENCE (WASHINGTON D C), vol. 266, no. 5187, 1994, pages 1024 - 1027, XP001147878, ISSN: 0036-8075 *
FARZAN M ET AL: "Stabilization of human immunodeficiency virus type 1 envelope glycoprotei trimers by disulfide bonds introduced into the gp41 glycoprotein ectodomain", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 72, no. 9, September 1998 (1998-09-01), pages 7620 - 7625, XP002097559, ISSN: 0022-538X *
LABRANCHE C C ET AL: "Biological, molecular, and structural analysis of a cytopathic variant from a molecularly cloned simian immunodeficiency virus.", JOURNAL OF VIROLOGY. UNITED STATES NOV 1994, vol. 68, no. 11, November 1994 (1994-11-01), pages 7665 - 7667, XP009010815, ISSN: 0022-538X *
LABRANCHE CELIA C ET AL: "Biological, molecular, and structural analysis of a cytopathic variant from a molecularly cloned simian immunodeficiency virus.", JOURNAL OF VIROLOGY, vol. 68, no. 9, 1994, pages 5509 - 5522, XP009010814, ISSN: 0022-538X *
See also references of WO0100648A1 *
TRKOLA ALEXANDRA ET AL: "Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp 120 glycoprotein of human immunodeficiency virus type 1.", JOURNAL OF VIROLOGY, vol. 70, no. 2, 1996, pages 1100 - 1108, XP002241179, ISSN: 0022-538X *

Also Published As

Publication number Publication date
AU782123B2 (en) 2005-07-07
JP2003509013A (ja) 2003-03-11
EP1198468A1 (fr) 2002-04-24
CA2370517A1 (fr) 2001-01-04
WO2001000648A1 (fr) 2001-01-04
HK1046911A1 (zh) 2003-01-30
AU5884200A (en) 2001-01-31

Similar Documents

Publication Publication Date Title
ATE200027T1 (de) Tetrahydrolipstatin enthaltende präparate
LU91437I2 (fr) "dabigatran-etexilate et ses sels- particulièrement dabigatran-etexilate-mésilate (PRADAXA)"
DE69827260D1 (de) Konjugate von transportpeptiden und nukleinsäureanaloga und deren verwendung
DE69737298D1 (de) Konjugate von polysacchariden und biomolekülen
EP1198468A4 (fr) Proteines d'enveloppe virale stabilisee et utilisations
ATE297761T1 (de) Zubereitungen zur stabilisierung von peg- interferon alpha konjugaten
DE69722329D1 (de) Postkarte und Umschlag
DE69811001D1 (de) Ausgeber von Briefumschlägen
DE69822113D1 (de) Registrierung von Dokumenten
FI963334A7 (fi) Tyrosinaasista peräisin olevat eristetyt peptidit ja niiden käyttö
HUP0003327A3 (en) Grapevine leafroll virus (type 2) proteins and their uses
DE69829434D1 (de) Ausgeber von Briefumschlägen
ATE325194T1 (de) Antithrombinnukleotide und -proteine von haematobia irritans
FR2786773B1 (fr) Proteines d'enveloppe, methodes et utilisations
FI953257A7 (fi) Rekombinanttinen ihmisen prostaspesifinen antigeeni ja sen käytöt
NO20005547D0 (no) Myelinbasiske proteinpeptider og anvendelser derav
FR2790450B3 (fr) Enveloppe d'expedition
PL350549A1 (en) Insect viral vectors and uses thereof
KR970002897U (ko) 절첩식 국기봉
FR2746075B3 (fr) Enveloppe
FR2761299B1 (fr) Ouvre enveloppe
EP1127066A4 (fr) Proteines modifiees
UA2031S (uk) Конверт міжнародної прискореної пошти
FI972010A0 (fi) Arrangemang i en borrningsanordning
FI972013A0 (fi) Arrangemang i en glasboejningsugn

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020125

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIN1 Information on inventor provided before grant (corrected)

Inventor name: BINLEY, JAMES, M.

Inventor name: MOORE, JOHN, P., DEPT OF MICROBIOLOGY AND IMMUNOL

Inventor name: SCHUELKE, NORBERT

Inventor name: MADDON, PAUL, J.

Inventor name: OLSON, WILLIAM, C.

A4 Supplementary search report drawn up and despatched

Effective date: 20030611

17Q First examination report despatched

Effective date: 20051219

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1046911

Country of ref document: HK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20120503